US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist

4.480
-0.410-8.38%

Close Jan 8 16:00 ET

4.480
0.0000.00%

Post 17:00 ET

241.65MMarket Cap-15.45P/E (TTM)

Fulcrum Therapeutics Stock Forum

Jaguar8

Sep 12, 2024 07:11

NEWS

$Fulcrum Therapeutics (FULC.US)$
Fulcrum Therapeutics Announces Topline Results from Phase 3 REACH Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics (NASDAQ: FULC) announced that its Phase 3 REACH trial for losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) failed to meet its primary endpoint. The trial showed no significant improvement in relative surface area (RSA) compared to placebo at week 48. Secondary endpoints also failed to ...

Trytosaveabit

Jul 31, 2024 12:53

Up is the way!

$Fulcrum Therapeutics (FULC.US)$ Low volume indeed! But low or high volume, all that matters is that it’s moving up nicely

Trytosaveabit

Jul 31, 2024 06:11

Talk about a under estimated or a killer unexpected operating income! Hehehe!

$Fulcrum Therapeutics (FULC.US)$ Fulcrum Therapeutics Q2 Operating Income USD 52.492 Million Vs. IBES Estimate USD 361.4 Thousand! Hope the rest of the earnings looks like this? hehehe

Trytosaveabit

May 23, 2024 08:23

Note the timeline

$Fulcrum Therapeutics (FULC.US)$ Its lead candidate, Losmapimod, is a selective p38α/β mitogen-activated protein kinase inhibitor. It is a potentially transformative treatment for FSHD, a rare and debilitating disease for which no approved treatments exist. The FDA has since granted Losmapimod Fast Track designation and Orphan Drug Designation for treating this condition. It is undergoing a Phase 3 study, and Fulcrum expects to report topline data in the fourth quarter of 2024.

jimmy the trader

May 14, 2024 14:06

Oh come on what are you waiting for we all know we goin up

$Fulcrum Therapeutics (FULC.US)$ Oh come on what are you waiting for we all know we goin up

jimmy the trader

May 14, 2024 11:27

FULL SEND LETS GO GOLDMAN I got 10K riding on it

$Fulcrum Therapeutics (FULC.US)$

jimmy the trader

May 13, 2024 15:32

Long term looking for dollar 15 range, possible 17 price target to hit. 13.7 resistance 10.4 Fulcrum . Hold

$Fulcrum Therapeutics (FULC.US)$ Long term looking for dollar 15 range, possible 17 price target to hit. 13.7 resistance 10.4 Fulcrum

Trytosaveabit

May 13, 2024 05:05

$Fulcrum Therapeutics (FULC.US)$ Fulcrum Therapeutics Inc: Fulcrum Will Receive an Upfront Payment of $80.0 Mln

Trytosaveabit

May 13, 2024 05:04

News

$Fulcrum Therapeutics (FULC.US)$ Reuters· 2 mins ago
Fulcrum Therapeutics Enters Into a Collaboration and License Agreement With Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy

Jaguar8

May 8, 2024 07:01

$Fulcrum Therapeutics (FULC.US)$
NEWS
Fulcrum Therapeutics Announces Publication of Results from Phase 2b Clinical Trial of Losmapimod in Facioscapulohumeral muscular dystrophy (ReDUX4) in The Lancet Neurology
Fulcrum Therapeutics, a biopharmaceutical company, published Phase 2b clinical trial results of losmapimod for FSHD in The Lancet Neurology. While not meeting the primary endpoint, losmapimod showed improvements in structural and functional outcomes, with Phase 3 data expected in Q4 2024.
P...

No comment yet

Heat List

Overall

No Data